TcrossGlobal

Randomized Trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy-Statin and Eicosapentaenoic Acid (RESPECT-EPA)

The RESPECT-EPA trial demonstrated that in patients with stable coronary artery disease who have a low eicosapentaenoic acid (EPA)/arachidonic acid (AA) ratio and are receiving statin therapy, treatment with icosapent ethyl tended to reduce the risk of cardiovascular events, Dr. Katsumi Miyauchi and colleagues, Juntendo University Graduate School of Medicine, Japan, reported in the August 6 issue of Circulation.

In this prospective, multicenter, randomized, open-label, blinded end-point study, patients with sta...

Continue reading this article

Select an option below:

Free Registration
Already have an account?
Log In

Introducing the main contents

Conference Reports

Timely delivery of scientific meetings from around the world, including AHA, ESC, TCT, EuroPCR, JCC, etc!

Complex PCI Cases

Features case reports on patients with complex lesions encountered in daily clinical practice.

Live Demonstration CoursesComing soon

In this section you will find live videos of catheter interventions for complex lesions.

What is TCROSS NEWS GLOBAL?

TCROSS NEWS Global, an affiliate of TCROSS Co., Ltd. Japan(established in 2005) is a cardiovascular news website which serves as a link between cardiologists, medical device manufacturers and industry stakeholders.
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.

Learn more about TCROSS NEWS Global

This website is automatically translated using Google Translate.